Headquartered in Riyadh, Boston Oncology Arabia is a fully integrated pharmaceutical company purpose-built for localization. The company develops, manufactures, and commercializes advanced generics, ...

Cancer patients can get all of their care in a single Ontario location that is well known, centrally located and easily ...

A new study has found for the first time that magnetoelectric nanoparticles—tiny, wirelessly controlled particles activated ...

AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide ...

Technology lies at the heart of ShardaCare's mission to enhance diagnosis, treatment, and recovery. ,, Times Now ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The streets of Bengaluru turned pink on Saturday morning, as over 30 women bikers and pink auto drivers rode together in ...

Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, and Nucleai, a leader in AI-powered multimodal spatial biology for precision medicine ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

Q3 2025 Management View Eric Lefkofsky, Co-Founder, CEO, President & Chairman, opened by highlighting that "Q3 was a great quarter all around. Our Genomics volume came in super strong with 33% overall ...

Q3 revenue at a record-high $387.2mn and $87.13mn EBITDA; 9M revenue at $1.12bn; 5.1mn patients use the group’s facilities ...

Hippocratic AI raises $126 million in Series C funding, reaching a $3.5 billion valuation to scale safe, generative AI ...